Program Area Leader
Post-Doctoral Fellow, Harvard Medical School and Scripps Research Institute, USA
Associate Professor, Faculdade de Farmácia, Universidade de Lisboa
Group Leader, Molecular Microbiology and Biotechnology at iMed.ULisboa
Drug discovery is tailored toward the challenge of developing novel clinically viable therapeutic agents and understanding how and when therapies work. Greater insight can be gained by integrating cell-based approaches with emerging “-omics” technologies and pathway modeling. We identify new targets for the engagement of rational drug design, using approaches not restricted to conventional small molecule drugs but also to the development of biopharmaceuticals targeting single molecules or complex interacting components of disease pathways.